Heavy magnesium oxide, all-rac-alpha-tocopherol acetate (Ph.Eur.) - Resultats de la cerca

Unió Europea - eslovè - EMA (European Medicines Agency)

colobreathe

teva b.v. - colistimethate natrijev - cistična fibroza - antibacterials za sistemsko uporabo, - colobreathe je navedeno za upravljanje kronične pljučne okužbe zaradi pseudomonas aeruginosa pri bolnikih s cistično fibrozo (cf), starih šest let in starejši. upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Unió Europea - eslovè - EMA (European Medicines Agency)

cortavance

virbac s.a. - hidrokortizon aceponat - kortikosteroidi, dermatološki preparati - psi - za simptomatsko zdravljenje vnetnih in pruritskih dermatoz pri psih. for alleviation of clinical signs associated with atopic dermatitis in dogs.

Unió Europea - eslovè - EMA (European Medicines Agency)

sevoflo

zoetis belgium sa - sevofluran - anestetiki, splošno - dogs; cats - za indukcijo in vzdrževanje anestezije pri psih in mačkah.

Unió Europea - eslovè - EMA (European Medicines Agency)

mekinist

novartis europharm limited - trametinib - melanoma - antineoplastična sredstva - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 in 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. non-small cell lung cancer (nsclc)trametinib v kombinaciji z dabrafenib je indiciran za zdravljenje odraslih bolnikov z napredovalim non-small cell lung cancer z braf v600 mutacija.

Unió Europea - eslovè - EMA (European Medicines Agency)

zerbaxa

merck sharp & dohme b.v. - ceftolozane sulfat, tazobactam natrijev - bakterijske okužbe - antibacterials za sistemsko uporabo, - zerbaxa is indicated for the treatment of the following infections in adults:complicated intra abdominal infections;acute pyelonephritis;complicated urinary tract infections;hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap). upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.